Literature DB >> 21833795

Linking dissolution to disintegration in immediate release tablets using image analysis and a population balance modelling approach.

David Wilson1, Stephen Wren, Gavin Reynolds.   

Abstract

PURPOSE: In order to achieve an improved understanding of disintegration and dissolution phenomena for an immediate release tablet formulation, a technique to monitor the number and size of particles entrained within the dissolution media was developed in combination with a population balancing model.
METHODS: Tablets were first characterized for crushing force, disintegration time and dissolution performance using standard USP methodologies. The performance of the tablets was then assessed using a new measurement system which links a "QicPic" particle imaging device to a USP dissolution vessel. This system enables us to measure the number and size of particles generated during tablet dissolution. The population balance mathematical model allowed a tablet erosion rate to be manipulated to fit the experimental data.
RESULTS: Results showed that tablets with differing crushing forces showed different dissolution behaviors that could be explained by differing rates of particle release into the dissolution media. These behaviors were then successfully modeled to provide a description of the dissolution and disintegration behavior of the tablets in terms of a tablet erosion rate.
CONCLUSIONS: A new approach was developed that allowed the description of the dissolution behaviors of the tablets in terms of the rate that they release particles into solution. This was then successfully modeled in terms of a tablet erosion rate.

Mesh:

Substances:

Year:  2011        PMID: 21833795     DOI: 10.1007/s11095-011-0535-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement.

Authors:  Carrie A Coutant; Michael J Skibic; Greg D Doddridge; Craig A Kemp; David C Sperry
Journal:  Mol Pharm       Date:  2010-09-01       Impact factor: 4.939

2.  An optical method for continuous monitoring of the dissolution rate of pharmaceutical powders.

Authors:  Riikka Laitinen; Jani Lahtinen; Pertti Silfsten; Erik Vartiainen; Pekka Jarho; Jarkko Ketolainen
Journal:  J Pharm Biomed Anal       Date:  2010-01-15       Impact factor: 3.935

3.  Understanding agglomeration of indomethacin during the dissolution of micronised indomethacin mixtures through dissolution and de-agglomeration modeling approaches.

Authors:  Peter J Stewart; Feng-Ying Zhao
Journal:  Eur J Pharm Biopharm       Date:  2005-02       Impact factor: 5.571

Review 4.  Current perspectives in dissolution testing of conventional and novel dosage forms.

Authors:  Shirzad Azarmi; Wilson Roa; Raimar Löbenberg
Journal:  Int J Pharm       Date:  2006-10-06       Impact factor: 5.875

5.  Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.

Authors:  Cheng Tong; Susan S D'Souza; Jan E Parker; Tahseen Mirza
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

6.  Prediction of granule packing and flow behavior based on particle size and shape analysis.

Authors:  Niklas Sandler; David Wilson
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

7.  A PAT approach to improve process understanding of high shear wet granulation through in-line particle measurement using FBRM C35.

Authors:  Jun Huang; Goldi Kaul; Julia Utz; Pedro Hernandez; Victor Wong; Daragh Bradley; Arwinder Nagi; Des O'Grady
Journal:  J Pharm Sci       Date:  2010-07       Impact factor: 3.534

8.  Deaggregation during the dissolution of benzodiazepines in interactive mixtures.

Authors:  J Liu; P J Stewart
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

9.  De-agglomeration of micronized benzodiazepines in dissolution media measured by laser diffraction particle sizing.

Authors:  Feng-Ying Zhao; Peter J Stewart
Journal:  J Pharm Pharmacol       Date:  2003-06       Impact factor: 3.765

10.  The impact of dose and solubility of additives on the release from HPMC matrix tablets--identifying critical conditions.

Authors:  Farhad Tajarobi; Susanna Abrahmsén-Alami; Magnus Hansen; Anette Larsson
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

View more
  4 in total

1.  A new approach to dissolution testing by UV imaging and finite element simulations.

Authors:  Johan P Boetker; Jukka Rantanen; Thomas Rades; Anette Müllertz; Jesper Ostergaard; Henrik Jensen
Journal:  Pharm Res       Date:  2013-01-11       Impact factor: 4.200

Review 2.  A Review of Disintegration Mechanisms and Measurement Techniques.

Authors:  Daniel Markl; J Axel Zeitler
Journal:  Pharm Res       Date:  2017-03-01       Impact factor: 4.200

3.  Investigating the Dissolution Performance of Amorphous Solid Dispersions Using Magnetic Resonance Imaging and Proton NMR.

Authors:  Francesco Tres; Steven R Coombes; Andrew R Phillips; Leslie P Hughes; Stephen A C Wren; Jonathan W Aylott; Jonathan C Burley
Journal:  Molecules       Date:  2015-09-10       Impact factor: 4.411

4.  Tablet Disintegration and Dispersion under In Vivo-like Hydrodynamic Conditions.

Authors:  Jan Lenz; Frederik Fuest; Jan Henrik Finke; Heike Bunjes; Arno Kwade; Michael Juhnke
Journal:  Pharmaceutics       Date:  2022-01-16       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.